On Monday Chembio Diagnostics (NASDAQ:CEMI) remained among the day gainers s and traded with change of -1.44% on volume of 57325 shares in the last session as compared to average volume of 64943 shares. During last trade its minimum price was $4.06 and it gained highest price of $4.91. CEMI has total market capitalization of $72369981. Its closing value stands at $4.12.
On Nov. 25, 2019, Chembio Diagnostics (NASDAQ:CEMI) a leading point-of-care diagnostics company focused on infectious diseases, released that it has completed its previously announced acquisition of Orangelife Comercio e Industria Ltda., a Brazilian manufacturer and distributor of point-of-care diagnostics tests for infectious diseases.
Our acquisition of Orangelife strategically broadens our commercialization by enhancing our presence in Brazil, which we view as one of the most attractive infectious disease testing markets in the world, said John Sperzel, Chembio’s Chief Executive Officer. We are excited to offer our leading point-of-care tests to the state, private and pharmacy markets, and provide additional local support to our long-time partner Bio-Manguinhos.
About Chembio Diagnostics
Chembio is a leading point-of-care diagnostics company focused on detecting and diagnosing infectious diseases. The company’s patented DPP technology platform, which uses a small drop of blood from the fingertip, provides high-quality, cost-effective results in approximately 15 minutes. Coupled with Chembio’s extensive scientific expertise, its novel DPP technology offers broad market applications beyond infectious disease, a number of which applications are under active development with collaboration partners. Chembio’s products are sold globally, directly and through distributors, to hospitals and clinics, physician offices, clinical laboratories, public health organizations, government agencies, and consumers.
Sam Leventhal is a self-taught investor and follows the value investing approach to picking stocks. He possesses over 10 years of investment experience, an M.B.A. from Louisiana State University, and is also certified in Risk Management Assurance. Sam is a Certified Internal Auditor, Data Miner, and author with a career broadly spanning over multiple business areas. He has exploited those observations and developed investment tactics within a fundamentally sound long-term investment strategy. He currently covers Technology News category for our site.
Email Contact – [email protected]
Address: 1894 MacLaren Street, Ottawa, Ontario
Zip Code: K1P 5M7
Phone Number: 613-785-7363